The minimal inhibitory concentrations of 601 clinical isolates of anaerobic bacteria to 10 different antimicrobial agents were determined by an agar-dilution technique. Nearly all strains were resistant to kanamycin and gentamicin, although moderate activity to both drugs was noted with Fusobacterium sp., anaerobic cocci, some strains of Bacteroides melaninogenicus, and nonsporeforming gram-positive bacilli. Chloramphenicol at 12.5 ,ug/ml inhibited all but three of the strains tested. Tetracycline at 6.25 ,ug/ml had high activity against all groups tested, with the exception that only 39% of strains of Bacteroidesfragilis were inhibited at this concentration. Excluding certain species of Bacteroides, the majority of anaerobes were inhibited by penicillin at 3.1 ,ug/ml or less and by cephalothin at 12.5 ,ug/ml or less. Lincomycin at 6.2 ,ug/ml or less was active against nearly all strains. Erythromycin at a concentration of 3.1 ,ug/ml was active against B. fragilis; however, erythromycin was less active against the other groups. Most of the minimal inhibitory concentrations of lincomycin exceeded those of clindamycin by fourfold; Rifampin inhibited virtually all strains at 3.1 /Ag/ml.
The minimal inhibitory concentrations of 601 clinical isolates of anaerobic bacteria to 10 different antimicrobial agents were determined by an agar-dilution technique. Nearly all strains were resistant to kanamycin and gentamicin, although moderate activity to both drugs was noted with Fusobacterium sp., anaerobic cocci, some strains of Bacteroides melaninogenicus, and nonsporeforming gram-positive bacilli. Chloramphenicol at 12.5 ,ug/ml inhibited all but three of the strains tested. Tetracycline at 6.25 ,ug/ml had high activity against all groups tested, with the exception that only 39% of strains of Bacteroidesfragilis were inhibited at this concentration. Excluding certain species of Bacteroides, the majority of anaerobes were inhibited by penicillin at 3.1 ,ug/ml or less and by cephalothin at 12.5 ,ug/ml or less. Lincomycin at 6.2 ,ug/ml or less was active against nearly all strains. Erythromycin at a concentration of 3.1 ,ug/ml was active against B. fragilis; however, erythromycin was less active against the other groups. Most of the minimal inhibitory concentrations of lincomycin exceeded those of clindamycin by fourfold; Rifampin inhibited virtually all strains at 3.1 /Ag/ml.
The increasing recognition of the role of anaerobic bacteria in infections has made it necessary for the clinician to become familiar with the classification and nomenclature of this large group of organisms. In contrast to the clinically significant aerobic and facultatively anaerobic bacteria, the fastidious nature of the anaerobic bacteria precludes the prompt performance of antimicrobial susceptibility tests. Therefore, appropriate antimicrobial therapy is contingent on awareness of the possibility of infection by anaerobic bacteria and familiarity with susceptibility patterns of these bacteria.
This report presents the minimal inhibitory concentrations (MIC) of 601 clinical isolates of anaerobic bacteria to 10 different antimicrobial agents. In addition, the minimal bactericidal concentrations (MBC) of several antibiotics against 25 isolates of Bacteroides fragilis from blood will be presented.
MATERIALS AND METHODS
All anaerobic bacteria tested represented isolates from clinical material submitted to the Section of Clinical Microbiology during portions of an 8-month period beginning in November 1970 [for the total experience during this period, with classification by specimen source and species isolated, see report by Martin (16) ]. Subcultures of anaerobic bacteria were made at the time of initial isolation and stored at 1 Presented at the Eleventh Interscience Conference on Antimicrobial Agents and Chemotherapy. Atlantic City, N.J., 19 to 22
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-42 C according to the methods described by Dowell and Hawkins (2) . The 601 strains examined in this study were selected primarily on the basis of source and frequency of isolation. In this laboratory, all specimens, other than those from the throat, sputum, vagina, stomach, urine, and stool, are examined routinely for the presence of anaerobes; anaerobic cultures are performed on other specimens only by special request.
Antimicrobial susceptibility testing was performed, with certain modifications, by the method of Finegold et al. (5) , by using the agar-dilution technique and the inocula-replicator device of Steers et al. (18) . Isolates were incubated anaerobically for 48 hr in thioglycolate medium (135-C, BBL) enriched with sterile rabbit serum and, when necessary, with menadione. The broth culture was diluted to provide an inoculum of 105 to 106 colony-forming units on the surface of the agar. Serial twofold dilutions of antibiotics were incorporated in brain-heart infusion (BHI) agar (BBL) with 5% sheep blood so as to yield final concentrations ranging from 0.1 to 25 ,ug/ml. These plates were prepared on the day before the test and stored overnight at room temperature, rather than at 4 C, to prevent the increased oxygen absorption which occurs at refrigerator temperatures. After inoculation, all plates were incubated, including controls with known MIC values, in an anaerobic incubator (National Appliance Co., Portland, Ore.) at 37 C using the GasPak (BBL) modification described by Gardner and Martin (8) . The MIC, which was determined after 48 hr of incubation, was defined as the lowest concentration permitting no growth, a barely visible fine haze, or not more than one discrete colony (3) .
The MBC of six antibiotics against 25 strains of B. 148 IN VITRO ANTIMICROBIAL SUSCEPTIBILITY fragilis isolated from blood were determined in the following manner. Twofold dilutions of penicillin G, tetracycline, chloramphenicol, lincomycin, clindamycin, and erythromycin were prepared in 1.0-ml amounts of BHI broth (BBL) containing 2% sheep blood. Forty-eight-hour broth cultures were diluted 1:100 in BHI broth containing 2% sheep blood; 1.0 ml of this suspension was added to each tube containing antibiotic so as to yield final concentrations ranging from 0.1 to 25 ,ug/ml. This inoculum provided adequate growth in the control tube (without antibiotic) within 48 hr. All tubes were incubated anaerobically (GasPak) at 37 C and examined at 48 hr. The MIC was defined as the lowest concentration of antibiotic that completely inhibited visible growth. MBC was determined by transferring 0.05 ml from each tube without visible or with barely visible growth to quarter sections of BHI agar plates (BBL) with 5% sheep blood and incubating anaerobically at 37 C for 48 hr. The lowest antibiotic concentration from which subcultures showed no growth represented the MBC.
Isolation, subculture, and most biochemical tests were carried out according to the procedures outlined by Dowell and Hawkins (2) using the GasPak (BBL) system. Prereduced media (Scott Laboratories, Inc., Chapel Hill, N.C.) were used for the differential carbohydrate fermentations. Identification and speciation of the anaerobic isolates was according to the criteria of Dowell and Hawkins (2) .
RESULTS
With the exception of certain species of Bacteroides, penicillin G was highly active, against most anaerobes tested, at 6.2 ,ug/ml or less (Table   1 (Table 6 ). Clindamycin, on the other hand, exhibited a high degree of activity against all anaerobes at 1.6 ,ug/ml or less (Table  7) . In general, the MIC of lincomycin exceeded those of clindamycin by fourfold.
Nearly all strains in this study were resistant to kanamycin and gentamicin, although both of these drugs showed some activity against the anaerobic cocci, the nonsporeforming grampositive bacilli, and strains of B. melaninogenicus and Fusobacterium fusiforme (Tables 8 and 9 ).
With rifampin, virtually all strains were inhibited at 3.1 ,ug/ml or less, with the exception of some strains in the genus Eubacterium (Table  10) .
The MBC of penicillin G (Table 11 ) and tetracycline (Table 12 ) against 25 strains of B. fragilis isolated from blood were generally four to eight times the MIC. The bactericidal concentration of chloramphenicol (Table 13) was eight or more times the bacteriostatic concentration, whereas with lincomycin (Table 14) , clindamycin (Table 15) , and erythromycin (Table 16 ), the MBC generally exceeded the MIC by at least 16-fold.
DISCUSSION
In contrast to the voluminous literature on in vitro susceptibility testing of clinically significant aerobic and facultatively anaerobic bacteria, only a few references exist with regard to the anaerobes, and most of these are concerned primarily with the nonsporeforming gram-negative bacilli (1, 9, 10, 14) . In these studies involving anaerobic bacteria, several different techniques were used, thereby making comparisons difficult. Moreover, only a few antibiotics were studied. In some of these studies, species differences were not taken into account. Recently, in vitro studies by Finegold despite the CO2 present in the body, has been reported (13) .
More than half of the 25 strains of B. fragilis tested failed to be killed at concentrations of each of six antibiotics attainable in serum at their normally recommended dosages. Bactericidal activity of these antibiotics tended to be inconsistent. These results are in disagreement with those obtained by Ingham et al. (12) using a replica-plating technique with velvet pads; however, it is likely that Ingham et al. used a smaller inoculuni of bacteria in the inhibitory phase of their test than we did. Moreover, their definition of significant growth was 20 or more colonies in subcultures of plates with no growth or with growth of not more than 19 colonies. Our MBC was defined by the absence of any growth on subculture of broth containing no or barely visible growth. These differences in results emphasize the desirability of standardization of the techniques and interpretations of bactericidal tests.
Although tetracycline has been considered to be the agent of choice in the treatment of infections due to penicillin-resistant strains of Bacteroides (4, 11, 13) , our data and those of others (1, 14, 19) demonstrating substantial resistance of these organisms to this antibiotic and its inconsistent bactericidal activity raise serious questions about this recommendation. The efficacy of chloramphenicol in the treatment of Bacteroides sepsis, however, has also been questioned recently by Kagnoff and Armstrong (15) . The need for a well-controlled prospective clinical study of antibiotic efficacy in bacteremia due to anaerobic bacteria is clear.
The antimicrobial susceptibility data accumulated from these 601 clinical isolates of anaerobic bacteria indicate certain definite patterns that should be helpful in the selection of appropriate antibacterial therapy. With the possible exception of blood culture isolates, we do not think at this time that routine antibiotic susceptibility testing can be performed with the same facility and frequency as can be performed on the aerobic bacteria. Periodic testing, however, probably should be carried out to detect any significant changes in patterns of resistance that may develop. Data correlating results of disc-diffusion susceptibility testing with MIC would be helpful in simplifying the routine susceptibility testing of anaerobic bacteria.
